Gestational trophoblastic diseases (GTD) comprise a spectrum of tumor and tumor-like conditions that originate from the fetal chorion. Trophoblastic tumors are fetal allograft in maternal tissues and present unique biological, immunological and pathological problems. Suction and evacuation followed by serial estimation of serum hCG and chemotherapy are the mainstay of treatment. Hysterectomy is the treatment of choice for patients with placental site trophoblastic tumors and also for persistent chemotherapy resistant uterine disease. This treatment may be unacceptable to the woman who wishes to retain her fertility. With quality of life issues becoming more important in medicine, therapies which preserve fertility, without compromising adequate treatment of the disease, should receive serious consideration. Laparoscopic hysterectomy and robotic hysterectomy are good options for women who are considered for surgery. Hysteroscopy also has a role in localizing and obtaining uterine (endometrial/myometrial) tissues for histopathological studies. It also helps in differentiating the diagnosis of gestational trophoblastic neoplasia from other conditions of raised serum hCG like ectopic pregnancy (cornual), incomplete abortion and nongestational trophoblastic tumors.
INTRODUCTION
Gestational trophoblastic diseases comprise of a spectrum of disorders characterized by abnormal and excessive proliferation of the chorionic villi. The spectrum of cellular proliferation includes as follows:
• Hydatidiform mole (complete or partial) • Invasive mole • Choriocarcinoma • Placental site trophoblastic tumor.
If there is any evidence of persistence of gestational trophoblastic disease (GTD), usually defined as persistent elevation of serum beta hCG (human chorionic gonadotrophin), the condition is referred to as gestational trophoblastic neoplasia (GTN). GTN includes invasive mole, choriocarcinoma and placental site trophoblastic tumor (PSTT). GTN are very curable. They arise from the products of conception in the uterus. The most common preceeding pregnancy is a hydatidiform mole. Choriocarcinoma most often follows a molar pregnancy, but can follow a normal pregnancy, ectopic pregnancy, or abortion and should always be considered when a patient has continued vaginal bleeding after the end of a pregnancy. The risk of malignancy after a complete mole is 10 to 15% and after a partial mole is 0.5%.
INVESTIGATIONS
A urine pregnancy test should be performed in all cases of persistent or irregular vaginal bleeding after a pregnancy event. Definitive diagnosis is made by histological examination of the products of conception.
The important investigative modalities are as follows: • Ultrasound • Serum beta-hCG levels • CT scanning for liver or other intra-abdominal metastases • MRI or CT scanning for brain metastases • Histology.
DIAGNOSIS OF POSTMOLAR GTN
The diagnosis of GTN is made on the basis of elevated hCG levels, supported, but not necessarily by histologic or radiologic evidence. The criteria for the diagnosis of postmolar GTN are as follows: 
WJOLS

MANAGEMENT
• Suction curettage: Suction and evacuation followed by gentle curettage is the first line of management for hydatidiform mole. Patient follow-up is very important and essential in these cases. Serum beta-hCG is estimated one day prior to and one day after suction and evacuation to detect the initial level. Then serum hCG serial estimation is done every two weeks till the levels are undetectable. Then serum hCG is done once a month for 6 months if the levels are negative and without any clinical symptoms.
• Chemotherapy for evidence of malignant disease.
• Hysterectomy is the treatment of choice for patients with:
-Placental site trophoblastic tumor (they are relatively resistant to chemotherapy) -Persistent chemotherapy resistant tumor -Women who has completed her childbearing -Uncontrolled vaginal or intra-abdominal bleeding due to the tumor • Radiotherapy (for some cases of distant metastases like brain metastases). 9 reported a case of a patient where after four cycles of methotrexate chemotherapy, a vascular tangle was noted that emerged from the right uterine horn, invading the broad ligament adjacent to the uterine artery. Doppler ultrasound along with magnetic resonance arteriography confirmed the diagnosis. The location, size and relation of this arteriovenous malformation to the uterine vasculature demanded urgent intervention. Laparoscopy was performed and bipolar coagulation of the ovarian and uterine artery feeding branches was achieved after surgical resection of the tumor. Lindholm et al 10 reported a study where three cases with elevated serum hCG had negative ultrasound and color Doppler studies. In these cases, myometrial biopsies containing tumors were obtained by means of hysteroscopy. Michael R et al 11 reported a case where a patient after methotrexate injection for ectopic pregnancy reached a plateau level of serum hCG 3 weeks later and then the level started to increase. She underwent dilatation and curettage that did not reveal any trophoblastic tissue. A diagnostic hysteroscopy that followed revealed occlude ostia of the left tube. The patient then had diagnostic laparoscopy that confirmed a mass in the left cornua, which was removed with wide wedge resection and histopathological examination revealed choriocarcinoma.
REVIEW OF LITERATURE
DISCUSSION
Despite advances in chemotherapy regimens for treating malignant GTN, hysterectomy and other extirpative procedures continue to play a role in the management of patients with both low-risk and high-risk GTN. Primary hysterectomy can reduce the amount of chemotherapy required to treat low-risk disease, 4 whereas surgical resection including hysterectomy, pulmonary resection and other extirpative procedures can be invaluable for treating highly selected patients with persistent drugresistant disease. Conservative myometrial resection combined with uterine reconstruction might be considered in highly selected patients with nonmetastatic GTN who wish to avoid hysterectomy. In a postpartum woman with urine pregnancy test positive but transvaginal sonography showing no intrauterine or extrauterine pregnancy, laparoscopy has an important role. 2 A normal laparoscopy can reasonably rule out an ectopic pregnancy and many nongestational trophoblastic neoplasia associated with raised serum hCG. Majority of women undergoing hysterectomy for malignant GTD are treated with abdominal hysterectomy. Laparoscopic-assisted vaginal hysterectomy and total laparoscopic hysterectomy has been used in few patients with GTN. This technique allows surveillance of the upper abdomen combined with shorter convalescence than abdominal hysterectomy. This procedure offers advantage that proper intra-abdominal inspection is possible, morcellation can be avoided (in laparoscopic-assisted vaginal hysterectomy) and the uterine arteries were transacted at their origin before uterine manipulation to avoid potential tumor embolization. In addition, an abdominal incision is not required and so the patient has shorter hospitalization, less pain, shorter convalescence and faster recovery for an earlier start of chemotherapy if required. With robotic hysterectomy, there is better visualization of the operative field with increased dexterity allowing more precise and controlled movements of the surgical instrument maneuvers. It does not require an uterine manipulator which may be contraindicated in the setting of GTD. It has faster recovery and excellent clinical outcome. Hysteroscopy can also play a role in some selective and peculiar situations of GTD both for diagnosis and therapeutic purpose. 
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